About Newleos Therapeutics
Newleos Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2024 in Delaware. It has reported $93,449,993 raised in one offering on Form D since February 2025. Its chief executive is David Donabedian.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2025 | Feb 24, 2025 | $93,449,993fully sold | 11 | $8.4M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Newleos Therapeutics's Form D filed Feb 24, 2025.
DD
David Donabedian
President and CEO, director
RH
Robert Hadfield
Executive officer
CW
Christoph Westphal
Director
MC
Ming Cheah
Director
RC
Raymond Camahort
Director
JM
John McCabe
Executive officer